# Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

Source: [Health & Medicine News -- ScienceDaily](https://www.sciencedaily.com/releases/2026/11/261111005911.htm) · 2026-11-13 · Medicine
Page: https://themorning.science/story/study-of-750-000-pregnancies-reveals-a-surprising-twist-about-ozempic-and-wegovy-18469747e998ae14
Kind: research · Impact: medium

## In brief

- A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy and similar drugs was not linked to increased pregnancy complications when used for weight loss.
- When prescribed for diabetes, early exposure was associated with a higher risk of premature birth.
- The source reports these findings; it does not give further details on the size of the risk.

## Why it matters

The results separate the pregnancy outcomes of GLP-1 drugs used for weight loss from those used for diabetes, which matters for clinicians and patients weighing these medications before or during pregnancy.

## Coverage

- [Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy](https://www.sciencedaily.com/releases/2026/11/261111005911.htm) — Health & Medicine News -- ScienceDaily, 2026-11-13

Tags: glp-1, pregnancy, obesity, diabetes, preterm birth

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science